Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (51-60 of 497) with videos related to

Pageof 50
Sort By:
European Urology Oncology|May 18, 2019
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?Daniel E Spratt, Felix Y Feng
European Urology|June 10, 2022
Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114Amar U Kishan, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|September 15, 2020
Absolute versus Relative Benefit of Androgen Deprivation Therapy for Prostate Cancer: Moving Beyond the Hazard Ratio to Personalize TherapyDaniel E Spratt, Jonathan D Tward
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2023
Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocolShearwood McClelland, Yilun Sun, Daniel E Spratt
Prostate Cancer and Prostatic Diseases|April 9, 2021
Importance of radiotherapy to the primary in metastatic hormone sensitive prostate cancerElisha T Fredman, Gordon Guo, Daniel E Spratt
European Urology|October 2, 2022
Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre StudyWilliam A Hall, Jonathan Shoag, Daniel E Spratt
European Urology Oncology|April 4, 2026
Re: Bertolo R, Pastore AL, Verze P, et al. Real-world Burden and Management of Late Genitourinary Toxicity after Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.005Shilpa Gupta, Maria Carmen Mir, Daniel E Spratt
European Urology|November 27, 2018
Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28Nicholas G Zaorsky, Daniel E Spratt, Pierre Blanchard
European Urology|April 27, 2013
Reply to Leah Bensimon, Samy Suissa, and Laurent Azoulay's letter to the editor re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16Daniel E Spratt, Zhigang Zhang, Michael J Zelefsky
JAMA Oncology|November 1, 2019
Biology vs Access to Care-Relative Contribution to Racial Disparities in Prostate Cancer-In ReplyRobert T Dess, Brandon A Mahal, Daniel E Spratt
Pageof 50

Showing results (51-60 of 497) with videos related to

Sort By:
Pageof 50
European Urology Oncology|May 18, 2019
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?Daniel E Spratt, Felix Y Feng
European Urology|June 10, 2022
Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114Amar U Kishan, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics|September 15, 2020
Absolute versus Relative Benefit of Androgen Deprivation Therapy for Prostate Cancer: Moving Beyond the Hazard Ratio to Personalize TherapyDaniel E Spratt, Jonathan D Tward
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2023
Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocolShearwood McClelland, Yilun Sun, Daniel E Spratt
Prostate Cancer and Prostatic Diseases|April 9, 2021
Importance of radiotherapy to the primary in metastatic hormone sensitive prostate cancerElisha T Fredman, Gordon Guo, Daniel E Spratt
European Urology|October 2, 2022
Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre StudyWilliam A Hall, Jonathan Shoag, Daniel E Spratt
European Urology Oncology|April 4, 2026
Re: Bertolo R, Pastore AL, Verze P, et al. Real-world Burden and Management of Late Genitourinary Toxicity after Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.005Shilpa Gupta, Maria Carmen Mir, Daniel E Spratt
European Urology|November 27, 2018
Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28Nicholas G Zaorsky, Daniel E Spratt, Pierre Blanchard
European Urology|April 27, 2013
Reply to Leah Bensimon, Samy Suissa, and Laurent Azoulay's letter to the editor re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16Daniel E Spratt, Zhigang Zhang, Michael J Zelefsky
JAMA Oncology|November 1, 2019
Biology vs Access to Care-Relative Contribution to Racial Disparities in Prostate Cancer-In ReplyRobert T Dess, Brandon A Mahal, Daniel E Spratt
Pageof 50